Cigna Demands FTC Retraction in Escalating Drug-Price Fight

The FTC said it stands by its study. “Just three companies control nearly 80% of the market that millions of Americans must use to purchase necessary drugs at high costs,” an agency spokesman said. “This is a complicated and opaque market, and the FTC is committed to using its clear authority to help the public and policymakers understand it.”